Diabetic Retinopathy

CLINICAL CHALLENGE 1 Credit CME A 47-Year-Old Woman Urgently Referred for Proliferative Diabetic Retinopathy Management JAMA Ophthalmology

OPHTHALMOLOGY 18m 29s Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME) JAMA Ophthalmology

DIABETIC RETINOPATHY 1 Credit CME Association of Gastric Bypass Surgery With Risk of Developing Diabetic Retinopathy Among Patients With Obesity and Type 2 Diabetes in Sweden: An Observational Study JAMA Ophthalmology

DIABETIC RETINOPATHY 1 Credit CME Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial JAMA

OPHTHALMOLOGY 25m 29s How to Read Articles That Use Machine Learning With Yun Liu, PhD JAMA

DIABETIC RETINOPATHY 1 Credit CME Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes JAMA Ophthalmology

DIABETES 1 Credit CME Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease: A Randomized Clinical Trial JAMA Ophthalmology

DIABETIC RETINOPATHY 1 Credit CME How to Read Articles That Use Machine Learning: Users’ Guides to the Medical Literature JAMA

DIABETES 1 Credit CME Assessment of the Quality, Content, and Readability of Freely Available Online Information for Patients Regarding Diabetic Retinopathy JAMA Ophthalmology

CLINICAL CHALLENGE 1 Credit CME A Patient With Type 1 Diabetes, Visual Acuity Loss, and Retinal Thickening JAMA Ophthalmology

DIABETES 1 Credit CME Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial JAMA Ophthalmology

OPHTHALMOLOGY 10m 35s Diabetic Retinal Screening in a Telemedicine Network JAMA Ophthalmology

OPHTHALMOLOGY 4m 53s Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy JAMA

OPHTHALMOLOGY 2m 13s Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy JAMA

OPHTHALMOLOGY 57s Vitreous Hyperreflective Foci Detection Algorithm JAMA Ophthalmology

OPHTHALMOLOGY 1m 39s Real-Time Fluorescein Angiography JAMA Ophthalmology

OPHTHALMOLOGY 6m 11s Patient-Reported Visual Function Outcomes Improve After Ranibizumab Treatment in Patients With Vision Impairment Due to ... JAMA Ophthalmology

OPHTHALMOLOGY 5m 29s Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008 JAMA

OPHTHALMOLOGY 6m 44s Treatment of Proliferative Diabetic Retinopathy Using Viscosurgery With Vital Dye JAMA Ophthalmology

OPHTHALMOLOGY 3m 18s New Viscodissection Instrument for Use With Microincisional Vitrectomy in the Treatment of Diabetic Tractional Retinal ... JAMA Ophthalmology